Opko Health (OPK)

Add to Watchlists
Create an Alert
8.14 -0.19  -2.28% NYSE Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
OPK Price Chart
View All Events

OPK Events

Date Type Description
Mar 03 Earnings Q4 2013 Opko Health, Inc Earnings Results. Estimate: -0.06.
Jan 08 Misc Opko Health Completes Acquisition of Laboratorio Arama De Uruguay Limitada
Dec 17 Misc Opko Investor Conference Call
Nov 11 Earnings Opko Announces Third Quarter 2013 Financial and Operating Highlights. Estimate: -0.06.
Aug 28 Misc AGM Event for Opko Health Inc
Aug 09 Earnings Opko Announces Second Quarter 2013 Operating and Financial Highlights. Estimate: -0.05.
May 09 Earnings Opko Announces First Quarter 2013 Operating and Financial Highlights. Estimate: -0.04.
View All Performance Charts

OPK Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Opko Health is up 15.95% over the last year vs S&P 500 Total Return up 23.54%, Globus Medical up 52.03%, and Abiomed up 38.90%.

Get Quote for

PDF Report for OPK

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download OPK Pro Report PDF

Portfolio Strategies Featuring OPK

Did Opko Health make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OPK Profile

  • Sector: Healthcare
  • Industry: Medical Devices
  • Headquarters Country: United States
  • Headquarters State/Province: Florida
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Surgical and Medical Instrument Manufacturing
  • NAICS Code: 339112
  • NAICS Industry: Medical Equipment and Supplies Manufacturing
  • NAICS Industry Code: 3391
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 33

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company. It operates through two reportable business segments: Pharmaceutical and Instrumentation. The Pharmaceutical segment consists of two operating segments: Pharmaceutical Research and Development, which focuses on the research and development of pharmaceutical products, diagnostic tests, and vaccines. The Instrumentation segment consists of ophthalmic instrumentation devices and the activities related to the research, development, manufacture, and commercialization of those products. The company was founded in October 1991 and is headquartered in Miami, Florida.

Recent Quotes

Symbol Price Chg Chg % Market Cap
OPK 8.14 -0.19 -2.28% 3.361B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.